Needham Maintains Buy on Trulieve Cannabis, Raises Price Target to $13.5
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Matt McGinley has maintained a Buy rating on Trulieve Cannabis (OTC:TCNNF) and increased the price target from $6.5 to $13.5, indicating a positive outlook on the company's future performance.
March 01, 2024 | 10:19 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Matt McGinley has reaffirmed a Buy rating on Trulieve Cannabis and raised the price target from $6.5 to $13.5.
The significant increase in the price target by a reputable analyst suggests a strong confidence in Trulieve Cannabis's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100